Roche to acquire biopharma firm Good Therapeutics for $250m

Retrieved on: 2022-09-08 11:11:30

Tags for this article:

Click the tags to see associated articles and topics

Roche to acquire biopharma firm Good Therapeutics for $250m. View article details on hiswai:

Excerpt

Roche has signed a definitive merger agreement for the acquisition of US-based Good Therapeutics for an upfront payment of $250m in cash.

Article found on: www.pharmaceutical-technology.com